[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GR3005682T3 - - Google Patents

Info

Publication number
GR3005682T3
GR3005682T3 GR920402010T GR920402010T GR3005682T3 GR 3005682 T3 GR3005682 T3 GR 3005682T3 GR 920402010 T GR920402010 T GR 920402010T GR 920402010 T GR920402010 T GR 920402010T GR 3005682 T3 GR3005682 T3 GR 3005682T3
Authority
GR
Greece
Prior art keywords
methyl
carbazol
imidazol
solvates
tetrahydro
Prior art date
Application number
GR920402010T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005682T3 publication Critical patent/GR3005682T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Saccharide Compounds (AREA)
GR920402010T 1986-12-17 1992-09-10 GR3005682T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630071A GB8630071D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (1)

Publication Number Publication Date
GR3005682T3 true GR3005682T3 (el) 1993-06-07

Family

ID=10609112

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402010T GR3005682T3 (el) 1986-12-17 1992-09-10

Country Status (18)

Country Link
US (1) US4835173A (el)
EP (1) EP0276559B1 (el)
JP (1) JP2732844B2 (el)
KR (1) KR880007073A (el)
AT (1) ATE79031T1 (el)
AU (1) AU608794B2 (el)
CY (1) CY1693A (el)
DE (1) DE3780940T2 (el)
DK (1) DK662787A (el)
ES (1) ES2051754T3 (el)
GB (1) GB8630071D0 (el)
GR (1) GR3005682T3 (el)
HK (1) HK36593A (el)
IE (1) IE60135B1 (el)
IL (1) IL84844A0 (el)
NZ (1) NZ222949A (el)
PH (1) PH25503A (el)
ZA (1) ZA879458B (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973594A (en) * 1986-12-17 1990-11-27 Glaxo Group Limited Medicaments
US5246941A (en) * 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5221687A (en) * 1988-09-01 1993-06-22 Glaxo Group Limited Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
EP1022025A3 (en) * 1991-06-26 2002-06-05 Sepracor, Inc. Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron
EP1181015A2 (en) * 1999-03-01 2002-02-27 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
JP2004525083A (ja) * 2000-10-30 2004-08-19 テバ ファーマシューティカル インダストリーズ リミティド 塩酸オンダンセトロンの新規結晶及び溶媒和物形態並びにその製法
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
KR20060113792A (ko) * 2001-01-11 2006-11-02 테바 파마슈티컬 인더스트리즈 리미티드 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
ATE364611T1 (de) 2002-04-29 2007-07-15 Teva Gyogyszergyar Zartkoeruee Verfahren zur herstellung von 1,2,3,9-tetrahydro- 9-methyl-3- (2-methyl-1h-imidazol-1-yl)methylö- h-carbazol-4-on
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
KR20040104677A (ko) * 2002-04-30 2004-12-10 비오갈 기오기스제르갸르 알티. 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
EP2186517A4 (en) * 2007-08-08 2010-08-18 Ibanez Juan Jose Legarda USE AND METHODS OF USING A SEROTONIN3 (5-HT3) RECEPTOR ANTAGONIST AND CHLORIDE CHANNEL MODULATOR FOR THE TREATMENT OF DRUG OR DRUG ADDICTION OR DEPENDENCE OR CENTER NERVOUS DISORDERS
CN112203650A (zh) * 2018-06-21 2021-01-08 雀巢产品有限公司 使用烟酰胺腺嘌呤二核苷酸(nad+)前体和至少一种酮或酮前体的组合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158970B (el) * 1981-06-09 1987-02-28 Ici Plc
NZ210940A (en) * 1984-01-25 1989-08-29 Glaxo Group Ltd 1,2,3-trihydro-3-(1h-imidazol-1-ylmethyl)-4h-carbazol-4-one derivatives and pharmaceutical compositions
GB8401888D0 (en) * 1984-01-25 1984-02-29 Glaxo Group Ltd Heterocyclic compounds
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.

Also Published As

Publication number Publication date
EP0276559A2 (en) 1988-08-03
PH25503A (en) 1991-07-24
CY1693A (en) 1994-01-14
JPS63165314A (ja) 1988-07-08
DE3780940T2 (de) 1992-12-24
DK662787D0 (da) 1987-12-16
NZ222949A (en) 1997-06-24
ES2051754T3 (es) 1994-07-01
EP0276559B1 (en) 1992-08-05
EP0276559A3 (en) 1989-10-18
ATE79031T1 (de) 1992-08-15
DK662787A (da) 1988-06-18
JP2732844B2 (ja) 1998-03-30
ZA879458B (en) 1988-11-30
IL84844A0 (en) 1988-06-30
AU8261787A (en) 1988-06-23
IE873415L (en) 1988-06-17
DE3780940D1 (de) 1992-09-10
AU608794B2 (en) 1991-04-18
US4835173A (en) 1989-05-30
IE60135B1 (en) 1994-06-01
HK36593A (en) 1993-04-23
GB8630071D0 (en) 1987-01-28
KR880007073A (ko) 1988-08-26

Similar Documents

Publication Publication Date Title
GR3005682T3 (el)
SE8503680L (sv) Indolderivat
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
IE873414L (en) Medicament for dementia
OA09194A (en) "Insecticidal treatment and compositions therefor".
DE3567211D1 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
AP9200355A0 (en) "Therapeutic agent"
EP0435177A3 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
ZA796789B (en) Novel 3,4-diaza-bicyclo (4.1.0) hept-2-en-5-ones, their preparation, and therapeutic agents containing these compounds
NO921086D0 (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
IE873231L (en) Medicaments
EP0317913A3 (en) Di(meth)acrylates, process for their preparation and their use
GR74782B (el)
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
EP0092386A3 (en) Hydantoin therapeutic agents
ZA874878B (en) Pyran derivatives
NZ223203A (en) Herbicidal compositions containing tetrahydrophthalimides and 1,3,5-triazin-2-yl-urea derivatives
李虎容 et al. OCCLUSAL CONSIDERATION FOR IMPLANTS
CS310487A1 (en) Connection for amplifier's output stage's transistor operating point adjustment
CS754186A1 (en) Aid for medical instruments' introduction
IT8722869V0 (it) Dispositivo perfezionato per l'abbronzatura artificiale integrale o parziale.